Orlando Ophthalmology Real Estate Investors LLC is categorized under in Orlando, FL and active since 2007.
Orlando Ophthalmology Real Estate Investors LLC was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a business, which does work in the B2B market, and is classified as a , under code number 525990 by the NAICS.
If you are seeking more information, feel free to contact Sharon A Smith at the company’s single location by writing to 105 Bonnie Loch Court, Orlando, Florida FL 32806 or by phoning (407) 428-0040. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Orlando Ophthalmology Real Estate Investors LLC |
| Contact Person: | Sharon A Smith |
| Address: | 105 Bonnie Loch Court, Orlando, Florida 32806 |
| Phone Number: | (407) 428-0040 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | |
| SIC Code: | 6726 |
| NAICS Code: | 525990 |
| Share This Business: |
Orlando Ophthalmology Real Estate Investors LLC was started in 2007 to provide professional under the SIC code 6726 and NAICS code 525990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Sharon A Smith for inquiries that concern Orlando Ophthalmology Real Estate Investors LLC by calling the company number (407) 428-0040, as your correspondence is most welcome. Additionally, the physical location of the single location of Orlando Ophthalmology Real Estate Investors LLC can be found at the coordinates 28.522526,-81.380775 as well as the street address 105 Bonnie Loch Court in Orlando, Florida 32806.
For its online presence, you may visit Orlando Ophthalmology Real Estate Investors LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.